Tau processing and tau-mediated inflammation differ in human APOEε2 and APOEε4 astrocytes

Summary

Alzheimer's disease (AD) and progressive supra-nuclear palsy (PSP) are both proteinopathies, characterized by the accumulation of tau aggregates. APOEε4 is the greatest genetic risk factor for developing AD, while APOEε2 is a significant risk factor for developing PSP. In the brain, astrocytes are the predominant producer of ApoE, but they are also important for inflammation and overall brain homeostasis. Although, tau inclusions appear frequently in astrocytes in both AD and PSP brains, their connection to ApoE remains unclear. Here, we show that hiPSC-derived APOE 2/2 astrocytes accumulate, process, and spread pathogenic tau aggregates more efficiently than isogenic APOE 4/4 astrocytes. Moreover, the APOE 2/2 astrocytes display a more robust inflammatory response, which could be of relevance for the disease course. Taken together, our data highlight a central role of ApoE in astrocyte-mediated tau pathology. © 2024 The Author(s).

Authors Mothes T, Konstantinidis E, Eltom K, Dakhel A, Rostami J, Erlandsson A
Journal iScience
Publication Date 2024 Nov 15;27(11):111163
PubMed 39524360
PubMed Central PMC11549983
DOI 10.1016/j.isci.2024.111163

Research Projects

Cell Lines